Jeff Bessen

Jeff Bessen is a commercial strategist at Sanofi's Specialty Care business unit, where they focus on immunology, ophthalmology, and oncology by leading market assessments for clinical-stage assets with a revenue potential exceeding $5 billion. They have previously served as an Engagement Manager at Health Advances, directing strategic initiatives in biopharma and precision medicine. Jeff holds a Ph.D. in Chemistry and Chemical Biology from Harvard University, where they developed novel protein tools for gene therapy. They are also a founding Co-Chair of the Health Advances Pro Bono Consulting practice and a passionate writer, sharing insights on genome editing and biotechnology with a broad audience.